PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Leveraging the power of T cells: Oxford team maps the future of cancer immunotherapy

A new review summarizes anti-tumor mechanism of T cells, immune escape, and potential therapeutic strategies

2025-10-24
(Press-News.org)

T cells play central roles in the adaptive immune response against cancer. Their functional inactivation is a primary driver of tumor progression, making the reactivation of T cell function a main goal in immunotherapy. The review details how T cells specifically recognize and eliminate malignant cells by engaging tumor antigen peptides presented by MHC molecules.

“T cells can specifically recognize tumor antigen epitopes presented by MHC molecules to clear malignant tumor cells. The targets that can be recognized by T cells in tumors mainly include two types”, the authors point out. Highly immunogenic, tumor-specific "neoantigens" derived from somatic mutations, and more widely shared "tumor-associated antigens" that are overexpressed in cancers.

The review also illustrates how tumors evade this immune surveillance through multiple mechanisms, including suppressing T cell activation, inducing T cell exhaustion within the immunosuppressive tumor microenvironment, undergoing immunoediting to lose target antigens, and creating physical barriers to T cell infiltration.

The team further provides a detailed discussion on the three major strategies of T cell-mediated immunotherapy:

Antibody-based therapies, such as immune checkpoint inhibitors that block inhibitory signals and bispecific T cell engagers that redirect T cells to tumors. Adoptive Cell Transfer (ACT), including Tumor-Infiltrating Lymphocyte (TIL) therapy, and genetically engineered CAR-T and TCR-T cell therapies, which have shown breakthrough success in hematological and solid malignancies, respectively. Cancer vaccines, designed to prime and boost endogenous T cell responses against tumor antigens.

"No single immunotherapy modality is sufficient to address the complex challenges of tumor heterogeneity, the immunosuppressive microenvironment, and on-target/off-tumor toxicities," explains Professor Dong. "The future lies in rationally designed combination therapies that integrate these approaches."

The review identifies two critical frontiers for current research on immunotherapy: first, the discovery of more precise tumor antigens and the establishment of corresponding T cell receptor libraries to develop broader, more specific therapies; second, a deeper mechanistic understanding of T cell biology to identify key functional subsets and biomarkers for improved patient stratification, and ultimately improving the response rate of tumor immunotherapy.

This work provides a robust framework of T cell-mediated immunity and immunotherapy for researchers and clinicians, outlining a clear path toward more effective and durable immunotherapies for cancer patients.

 

***

 

Reference
DOI: 10.1007/s44466-025-00007-z

 

About Immunity & Inflammation
Immunity & Inflammation is a newly launched open-access journal co-published by the Chinese Society for Immunology and Springer Nature under the leadership of Editors-in-Chief Prof. Xuetao Cao and Prof. Jules A. Hoffmann. Immunity & Inflammation aims to publish major scientific questions and cutting-edge advances that explore groundbreaking discoveries and insights across the spectrum of immunity and inflammation, from basic science to translational and clinical research.
Website: https://link.springer.com/journal/44466

 

About Authors
Tao Dong
Professor Tao Dong is the Ita Askonas Professor of Translational Immunology at the Nuffield Department of Medicine, University of Oxford, and the UK Director of the Chinese Academy of Medical Sciences (CAMS) Oxford Institute. She leads the T Cell Laboratory at the Medical Research Council (MRC) Human Immunology Unit, University of Oxford. Her research focuses on the function of antigen-specific cytotoxic T cells, utilizing advanced single- and multi-omics technologies alongside T cell functional assessment platforms to investigate the critical role of T cells in controlling viral infections and cancer progression.

Adam Bates
Dr. Adam Bates is a Postdoctoral Research Scientist in Professor Tao Dong's group at the Chinese Academy of Medical Sciences Oxford Institute. His research aims to clarify the immune response mechanisms of CD8+ T cells in non-small cell lung cancer (NSCLC). By utilizing advanced technologies such as single-cell RNA and T cell receptor (TCR) sequencing, along with spatial transcriptomics, he seeks to identify T cell populations capable of recognizing and attacking tumors without exhibiting classical exhaustion features. This work lays a solid foundation for developing next-generation anti-tumor immunotherapies.

 

Funding information
This work was supported by Chinese Academy of Medical Sciences Innovation Fund (2024-I2M-2-001-1) and UK Medical Research Council (MR/Y015347/1).

END



ELSE PRESS RELEASES FROM THIS DATE:

Deep emission cuts before mid-century decisive to reduce long-term sea-level rise legacy

2025-10-24
Rising seas are irreversible on human time scales and among the most severe consequences of climate change. Emissions released in the coming decades will determine how much coastlines are reshaped for centuries to come. New research shows that near-term mitigation could spare future generations around 0.6 meters of sea-level rise that would be caused by emissions between 2020 and 2090 following current policies, making today’s decisions critical not only for limiting warming but also for coastal ...

New research uncovers how the brain’s activity, energy use, and blood flow change as people fall asleep

2025-10-24
Findings from Mass General Brigham investigators highlight the intricate interplay of diverse physiological processes as the brain shifts from wakefulness to sleep A new study by investigators from Mass General Brigham used next-generation imaging technology to discover that when the brain is falling asleep, it shows a coordinated shift in activity. They found that during NREM (non-rapid eye movement) sleep, parts of the brain that handle movement and sensory input stay active and keep using energy, while ...

Scientists develop floral-scented fungus that lures mosquitoes to their doom

2025-10-24
In the battle against mosquito-borne diseases that kill hundreds of thousands of people each year, scientists turned to an unlikely ally: a fungus that smells like flowers. Taking advantage of the mosquito’s natural attraction to flowers, an international team of researchers engineered a new strain of Metarhizium fungus that imitates a flower’s sweet scent and lures the bloodsucking bugs to their deaths.  Inspired by certain fungi that the team found emit a sweet-smelling chemical called longifolene to draw ...

Discovery of elusive solar waves that could power the Sun's corona

2025-10-24
Researchers have achieved a breakthrough in solar physics by providing the first direct evidence of small-scale torsional Alfvén waves in the Sun's corona – elusive magnetic waves that scientists have been searching for since the 1940s. The discovery, published today in Nature Astronomy, was made using unprecedented observations from the world's most powerful solar telescope, the U.S. National Science Foundation (NSF) Daniel K. Inouye Solar Telescope in Hawaii. The findings could finally explain one of the Sun's greatest mysteries ...

Protection against winter vomiting bug spread with arrival of agriculture

2025-10-24
Winter vomiting disease is caused by the Norovirus, which is most virulent during the colder half of the year. The infection clears up after a couple of days, but the protection it provides is short-lived, meaning that the same person can fall repeatedly sick in a short space of time. But some people cannot succumb to the virus, thanks to a particular gene variant. “We wanted to trace the historical spread of the gene variant,” says Hugo Zeberg, senior lecturer in genetics at the Department of Physiology and Pharmacology, Karolinska Institutet, and researcher at the Max Planck Institute for Evolutionary Anthropology in Leipzig.   Defective gene protects against ...

Key nervous system components shown to influence gastrointestinal tumour growth

2025-10-24
New research finds that common nervous system components are present in the gastrointestinal tract where they influence tumour growth, revealing untapped opportunities for cancer treatment. GLOBAL: Australian researchers have identified two nervous system components that drive tumour growth in gastrointestinal cancers, creating promising new avenues for treatment with existing approved therapies.   Our gut contains its very own nervous system and is commonly regarded as the second brain. Key players of this system are neuropeptides, the signalling ...

A food tax shift could save lives – without a price hike in the average shopping basket

2025-10-24
More expensive steak, cheaper tomatoes, but the same total cost for the average basket of groceries at the supermarket. A comprehensive study, led by researchers from Chalmers University of Technology in Sweden has analysed the potential effects of a food tax shift – where VAT is removed from healthy foods and levies are introduced on foods that have a negative impact on the climate. The study shows that a shift in taxes could have both environmental and human health benefits, and means that 700 fewer people in Sweden would die prematurely each year. Today, diet in many high-income countries is a leading risk factor for certain diseases and premature ...

Development of new candidate agent for lethal and severe cutaneous drug reaction

2025-10-24
Niigata, Japan - A collaborative research group led by Haruna Kimura (graduate student), Dr. Akito Hasegawa (Assistant Professor), and Prof. Riichiro Abe from the Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, together with Prof. Takemasa Ozawa from the Department of Chemistry, School of Science, The University of Tokyo, and Dr. Yoichi Ogawa (Lecturer) from the Department of Dermatology, Faculty of Medicine, University of Yamanashi, has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). SJS/TEN are severe ...

Teenagers and young adults who use cannabis have a higher risk of progressing to regular tobacco use

2025-10-23
Teens and young adults who use cannabis are more likely to become regular tobacco users – even if they haven’t previously tried tobacco – compared to similar people who do not use cannabis, suggests a US study published online in the journal Tobacco Control. Around 13% of new onset tobacco use was estimated to be attributable to cannabis, the study found. Tobacco smoking has been considered a gateway to cannabis use since the 1970s when smoking was much more prevalent and when almost all people who used cannabis had smoked tobacco first. Although tobacco use among teens and young adults has declined considerably ...

Baltic countries lead the way in supporting media freedom internationally, according to new index

2025-10-23
The Baltic states have emerged as global leaders in promoting media freedom internationally, according to a new Index on International Media Freedom Support (IMFS). The IMFS Index evaluates countries on how actively they support media freedom beyond their borders through diplomatic, funding and safety efforts. It is published by an independent group of academics at the University of East Anglia and City St George’s, University of London. Lithuania topped the Index, reflecting its strong diplomatic efforts to advance media freedom and its visa program supporting journalists in exile, including from Belarus and Russia. Estonia ranked 4th, ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Leveraging the power of T cells: Oxford team maps the future of cancer immunotherapy
A new review summarizes anti-tumor mechanism of T cells, immune escape, and potential therapeutic strategies